Chloé Cuypers’ Post

Here are some highlights from the recent Intraceuticals Global Proprietary Oxygen Treatment Skill Contest 2024 China Region Final. Meticulously organized by the Intraceuticals Asia team and held at the exquisite Yuluxe Sheshan, Shanghai, a Tribute Portfolio Hotel, this event showcased our clinic partner's talent, innovation, and dedication to skincare excellence.   As the competition unfolded, the competitors had an opportunity to demonstrate their mastery of the craft and their deep understanding of Intraceuticals' cutting-edge treatments. Meanwhile, the judges, renowned experts in the field, offered insightful comments and critiques, recognizing the standard of technical proficiency and the creativity and ingenuity displayed by each contestant.   Intraceuticals continues to set the standard for excellence in skincare, and events like these reaffirm their commitment to innovation and education within the industry. #Intraceuticals #IntraceuticalsAsia 

Did you know that a fast product launch can transform your market position in just three months? Many distributors struggle with slow and inefficient product launches, leading to missed market opportunities and lost revenue. Imagine launching a new product within three months, complete with a full marketing campaign and regulatory compliance. At TheOTCLab, we make this possible.  Our process ensures you hit the market quickly and effectively. For example: Our recent launch of Dr. Yglo in multiple European countries was completed in record time, driving a 50% increase in sales. We are constantly searching for partners to launch our products. Any tips? Let me know! #partners #otc #productlaunch

Japan Market Entry - Featuring a Super Quick Revenue Channel! Foreign Med-Tech companies trying to conduct business in Japan, the world's 2nd largest medical market, may find it challenging, but it can be extremely rewarding if done correctly!  We at Network in Motion Ltd - Japan Business & Investment Boutique are happy to share insights into how #MedTech companies looking to gain early traction in #Japan, can use an innovative pathway: Doctor's Private Import. This channel allows Japanese physicians to directly procure foreign medical devices for clinical use, bypassing the need for full market registration. Why use this approach? 1. Quick Access: Start generating revenue before having #FDA or #PMDA approvals. 2. Proof of Concept: Build credibility with real-world results from Japanese healthcare institutions. 3. Market Insights: Receive invaluable feedback from local doctors on product performance and adaptability. Pro Tip: To succeed with this strategy, align with a consulting partner familiar and experienced in Japan’s regulatory and distribution strategies. #CEOs, #BusinessDevelopmentManagers, and #JapanCountryManagers - contact us to explore how to make it happen! #JapanDoctorPrivateImport #JapanBusiness #JapanMarketEntry #HealthcareInnovation Terumo Medical Corporation #JapanBusinessConsulting IceCure Medical #FemTech MedTech Commercialization Institute #AgeTech #WomenHealthJapan #MedTechInvestment

🗞️ New interview!    CARB-X Chief of Research and Development Erin Duffy, PhD spoke with WuXi AppTec about CARB-X's pivotal work to advance innovative antibacterial products through the development pipeline. She discussed some of the projects CARB-X is supporting and the challenges that are encountered in early drug development in the antimicrobial resistance (AMR) industry. CARB-X launched several Portfolio Acceleration Tools to address these challenges, benefit the larger AMR ecosystem, and accelerate drug development. “We’ve observed common hurdles. One approach could be to address these individually, but we’ve found it more effective to take a proactive approach,” said Dr. Duffy. “Our goal is simple: if we can clear a path for one, we aim to clear it for all.” 🔗 Read here: bit.ly/3CACbea #AMR #StopSuperBugs #SuperBugs #AntibioticResistance #Medicine #GlobalHealth #ProductDevelopment #Innovation #Biotechnology

What happens when a homegrown business entrusts their brand and people with Singtel and goes on a reality makeover show? "Singapore Dreamin'" is what happens. A brand new series that goes beyond the typical makeover genre, but has all the heart and feels to rival any of them out there. "Singapore Dreamin'" isn't just a show—it's a celebration of entrepreneurial spirit and local innovation. Most of all, it’s a tribute to hard work and striving that Singaporeans know well. Bringing this vision to life is an incredible team of creative powerhouses: - Host: Irene Ang - Creative Leadership: Phin Wong & Jason James Riley - Director: Esan Sivalingam - Production: Hoods Inc Special mention goes to Singtel’s own powerhouse Lynette Poh for her tenacity and vision. Our first episode spotlights ICM Pharma featuring their second-generation leader, Dr. Stuart Koe. Their story is a testament to the resilience and innovation of Singapore's small and medium businesses. This series is Singtel’s tribute to the 99% of SMBs that form the backbone of our community. As Singapore turns 60 next year, we're honoured to support these incredible leaders and play a part to help unlock new possibilities for their businesses, employees, and families. Catch "Singapore Dreamin'" on Singtel, SPH Media and MediaCorp Pte Ltd’s MeWatch. Wendy Liang Law Xin Ye Kieran Cheang Jace C. Jennifer Ng Lionel Ch'ng Kwang Yong Lee Angie Ong Harish Nambiar Jessecca Lee #HelloPossibilities #SingaporeDreamin #SMBInnovation #SingtelMarcomms #SingtelChamps #SG60 #brandpartnerships #smb #realitytv

China’s significant share of the global ADC pipeline, growing role in licensing deals, supportive policies, and strong outsourcing services make it a dominant force in the ADC market. As global companies seek innovation, collaboration, and cost-effective solutions, China is poised to lead in next-gen ADC development. Keep an eye on this evolving market and explore opportunities for collaboration, investment, and research in China’s growing ADC industry.   Download our FREE eBook: 𝐇𝐨𝐰 𝐀𝐫𝐞 𝐀𝐃𝐂 𝐃𝐫𝐮𝐠 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐂𝐡𝐢𝐧𝐚'𝐬 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲? here: https://lnkd.in/g6zsiEDF

New players are innovating in the fast-growing vaping industry. Vaporesso integrates new tech like dedicated chips and simplifies vaping operations. Parent company Smoore recently IPO'd at $21B. Evolv solves key issues like temperature control and filed patents around it. They even sued Joytech for infringement. Evolv is US-based so good for geographic expansion. Indose enables precise medication dosing via vaping. Backed by Snoop Dogg, Indose provides unique medical solutions. With vaping gaining momentum, track innovations and early file patents. Buy assets early as licensing rates will be better. We can help find the right patents to buy based on your needs. #Vaping #ECigarettes #StartUps #IP Read more here: https://lnkd.in/dZjVg_c8 #GreyB #Innovation #Patents

"Willful blindness" at all levels of society, academia, clinical medicine and government. But what about industry or specifically the manufacturers? Were they blind? Their data proves they were not. #covid #Pfizer #moderna #vaccineinjury #healthcare #fda #cdc #fauci #pharma #pharmaceuticalindustry https://lnkd.in/eQU5m2ca

Thanks #citeline #invivo repost my recent interview with EY parnter Su on a range of issues impacting many health players in China, as more medtech and pharma companies are weighing options to stay where they are, to expand or to further localize #medtech #derisking #tenders #vbp

Pharma, medical, and biotech had a bigger year-on-year upswing in APAC than any other sector with US$80.6bn worth of transactions in 2023, jumping 59% compared to 2022. What opportunities will this create for M&A in the sector? Learn more from our Deal Drivers: APAC FY 2023 report. #wheredealsaremade #mergersandacquisitions